Nina M. Wolf - Concepedia

Author

Nina M. Wolf

University of Illinois Chicago

Also Known As

N. Wolf, Nina M. Wolf, Nina M. Wolf (6663317), Wolf, Nina M.

Publications

371

Citations

H-Index

Concepts

All Affiliations

University of Illinois Chicago Myongji University Ashland (United States)

About

Nina M. Wolf is an author at University of Illinois Chicago specializing in drug discovery, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	114
2	Biochemistry	3	3	90
3	Natural Sciences	2	2	78
4	Microbiology	2	2	36
5	Chemical Biology	1	1	68

Nina M. Wolf

Publications

345

Citations

H-Index

Page 1

	Year	Citations
Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus Mary Choules, Nina M. Wolf, Hyun Lee, Antimicrobial Agents and Chemotherapy	2019	114
High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads Nina M. Wolf, Hyun Lee, Mary Choules, ACS Infectious Diseases Ecu BindingDrug TargetProtein AssemblyMolecular BiologyAntimicrobial Chemotherapy	2019	68
Antimycobacterial Rufomycin Analogues from <i>Streptomyces atratus</i> Strain MJM3502 Bin Zhou, Gauri Shetye, Yu Yang, Journal of Natural Products	2020	49
Structure of the N-terminal domain of ClpC1 in complex with the antituberculosis natural product ecumicin reveals unique binding interactions Nina M. Wolf, Hyun Lee, Daniel Zagal, Acta Crystallographica Section D Structural Biology	2020	46
Identification of Bacillus anthracis PurE inhibitors with antimicrobial activity Anna Kim, Nina M. Wolf, Tian Zhu, Bioorganic & Medicinal Chemistry Antifungal AgentAntibioticsMedicineAntimicrobial ActivityAntimicrobial Chemotherapy	2015	24
Structures of SAICAR synthetase (PurC) from <i>Streptococcus pneumoniae</i> with ADP, Mg<sup>2+</sup>, AIR and Asp Nina M. Wolf, Celerino Abad‐Zapatero, Michael E. Johnson, Acta Crystallographica Section D Biological Crystallography BiosynthesisAntimicrobial Drug DiscoveryBiochemistryMedicineVirulence Factor	2014	12
Enzymatic Characterization of Fructose 1,6-Bisphosphatase II from Francisella tularensis, an Essential Enzyme for Pathogenesis Hiten J. Gutka, Nina M. Wolf, Jasper Marc G. Bondoc, Applied Biochemistry and Biotechnology	2017	12
Identification of B. anthracis N5-carboxyaminoimidazole ribonucleotide mutase (PurE) active site binding compounds via fragment library screening Hao Lei, Chris S. Jones, Tian Zhu, Bioorganic & Medicinal Chemistry Molecular CharacterizationDrug TargetBiochemistryN5-carboxyaminoimidazole Ribonucleotide MutaseMedicine	2015	10
Structures of the<i>Mycobacterium tuberculosis</i>GlpX protein (class II fructose-1,6-bisphosphatase): implications for the active oligomeric state, catalytic mechanism and citrate inhibition Nina M. Wolf, Hiten J. Gutka, Farahnaz Movahedzadeh, Acta Crystallographica Section D Structural Biology	2018	10

Page 1